not losing weight on .5 semaglutide Why Am I Semaglutide, and What to Do? CONS: ⚠️ Gastrointestinal side effects:

3

After completing the intensive initial treatment phase of 4-6 months, we transition patients to a maintenance phase with reduced injection frequency

Your clinician reviews your medical history, goals, and biomarkers to determine eligibility

This copper-bound form is primarily used in research, as copper plays an essential role in many biological mechanisms being studied

Key Takeaways Retatrutide is a once-weekly injectable triple agonist targeting GLP-1, GIP, and glucagon receptors Starting dose is typically 1 mg weekly, titrating up gradually to minimize side effects Maintenance doses range from 8 mg to 12 mg weekly based on individual response Titration is critical for balancing weight loss efficacy with tolerability Clinical trials show significant weight reduction compared to placebo Always work with a healthcare provider to determine your optimal dosing schedule Overview of Retatrutide What is Retatrutide